Natalizumab in Multiple Sclerosis: Long-Term Management.

Autor: Clerico M; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. marinella.clerico@unito.it., Artusi CA; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. caartusi@gmail.com., Liberto AD; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. ale.dili@hotmail.it., Rolla S; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. simona.rolla@unito.it., Bardina V; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. valentina.bardina87@gmail.com., Barbero P; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. p.barbero@isiline.it., Mercanti SF; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. sdemercanti@yahoo.it., Durelli L; Clinical and Biological Sciences Department, University of Torino, Orbassano (TO) 10043, Italy. luca.durelli@unito.it.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2017 Apr 29; Vol. 18 (5). Date of Electronic Publication: 2017 Apr 29.

Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab.

Autor: Hersh, Carrie M, Pang, Menglan, Miller, Deborah M, McGinley, Marisa P, Hyland, Megan, Ziemssen, Tjalf, Avila, Robin L

Publikováno v: Neurodegenerative Disease Management; Apr2024, Vol. 14 Issue 2, p21-33, 13p

Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among US Adults and Children, 2001 Through 2020.

Autor: Henderson, Mackenzie, Horton, Daniel B., Bhise, Vikram, Pal, Gian, Bushnell, Greta, Dave, Chintan V.

Publikováno v: JAMA Neurology; Aug2023, Vol. 80 Issue 8, p860-867, 8p

Identification of CD4⁺ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment.

Autor: Fagone, Paolo¹ (AUTHOR), Mazzon, Emanuela² (AUTHOR), Mammana, Santa² (AUTHOR), Di Marco, Roberto³ (AUTHOR), Spinasanta, Flaminia¹ (AUTHOR), Basile, Maria Sofia¹ (AUTHOR), Petralia, Maria Cristina² (AUTHOR), Bramanti, Placido² (AUTHOR), Nicoletti, Ferdinando¹ (AUTHOR) ferdinic@unict.it, Mangano, Katia¹ (AUTHOR)

Publikováno v: Molecular Medicine Reports. Jul2019, Vol. 20 Issue 1, p678-684. 7p.

Innovative therapeutic concepts of progressive multifocal leukoencephalopathy.

Autor: Möhn, Nora, Grote-Levi, Lea, Hopfner, Franziska, Eiz-Vesper, Britta, Maecker-Kolhoff, Britta, Warnke, Clemens, Sühs, Kurt-Wolfram, Wattjes, Mike P., Höglinger, Günter U., Skripuletz, Thomas

Publikováno v: Journal of Neurology; May2022, Vol. 269 Issue 5, p2403-2413, 11p